Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-17 4:00 pm Purchase | 2023-02-10 | 13D | ANNEXON INC ANNX | Satter Muneer A | 7,679,521 15.000% | 2,647,058 (+52.60%) | Filing History |
| 2023-02-14 4:18 pm Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | Redmile Group, LLC | 4,897,575 9.900% | 5,882 (+0.12%) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | Venrock Healthcare Capital Partners II, L.P. | 4,929,000 9.990% | 3,000,523 (+155.59%) | Filing History |
| 2023-02-14 3:45 pm Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | Fairmount Funds Management LLC | 3,681,456 7.700% | 1,112,056 (+43.28%) | Filing History |
| 2023-02-14 1:40 pm Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | Eventide Asset Management, LLC | 3,626,508 7.600% | 776,508 (+27.25%) | Filing History |
| 2023-02-14 06:41 am Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | Bain Capital Life Sciences Fund, L.P. | 4,886,616 11.000% | 1,945,989 (+66.18%) | Filing History |
| 2023-02-13 7:08 pm Sale | 2023-02-14 | 13G | ANNEXON INC ANNX | AllianceBernstein L.P. | 39,538 0.000% | -2,024,467 (-98.08%) | Filing History |
| 2023-02-13 6:00 pm Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | BIOTECHNOLOGY VALUE FUND L P | 3,780,694 7.900% | 437,500 (+13.09%) | Filing History |
| 2023-02-09 12:36 pm Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,195,761 8.690% | 11,200 (+0.27%) | Filing History |
| 2023-02-03 11:50 am Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | PICTET ASSET MANAGEMENT SA | 1,232,713 2.590% | 1,174,029 (+2000.59%) | Filing History |
| 2023-02-01 10:07 am Purchase | 2022-12-31 | 13G | ANNEXON INC ANNX | FEDERATED HERMES INC. FHI | 3,057,800 6.420% | 1,032,200 (+50.96%) | Filing History |
| 2022-07-18 5:16 pm Purchase | 2022-07-07 | 13G | ANNEXON INC ANNX | Redmile Group, LLC | 4,891,693 9.900% | 1,662,776 (+51.50%) | Filing History |
| 2022-07-18 4:45 pm Purchase | 2022-07-07 | 13D | ANNEXON INC ANNX | Satter Muneer A | 5,032,463 10.400% | 3,077,485 (+157.42%) | Filing History |
| 2022-07-18 4:30 pm Purchase | 2022-07-07 | 13G | ANNEXON INC ANNX | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,184,561 8.680% | 4,184,561 (New Position) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | ANNEXON INC ANNX | BlackRock Inc. BLK | 961,043 2.500% | -1,653,548 (-63.24%) | Filing History |
| 2022-06-23 4:05 pm Purchase | 2022-06-13 | 13G | ANNEXON INC ANNX | Venrock Healthcare Capital Partners II, L.P. | 1,928,477 5.000% | 1,928,477 (New Position) | Filing History |
| 2022-05-26 5:09 pm Purchase | 2022-05-16 | 13G | ANNEXON INC ANNX | BIOTECHNOLOGY VALUE FUND L P | 3,343,194 8.700% | 3,343,194 (New Position) | Filing History |
| 2022-04-21 10:00 am Purchase | 2022-04-11 | 13G | ANNEXON INC ANNX | Fairmount Funds Management LLC | 2,569,400 6.700% | 2,569,400 (New Position) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | ANNEXON INC ANNX | Redmile Group, LLC | 3,228,917 8.400% | -219,113 (-6.35%) | Filing History |
| 2022-02-14 3:54 pm Purchase | 2022-02-14 | 13G | ANNEXON INC ANNX | AllianceBernstein L.P. | 2,064,005 5.400% | 2,064,005 (New Position) | Filing History |